Monoclonal antibodies derived from B cells in subjects with cystic fibrosis reduce Pseudomonas aeruginosa burden in mice
M. Hale, K. K. Takehara, C. D. Thouvenel, D. A. Moustafa, A. Repele, M. F. Fontana, J. Netland, S. McNamara, R. L. Gibson, J. B. Goldberg, D. J. Rawlings, M. Pepper
The paper isolates PcrV-specific B cells from cystic fibrosis patients and generates monoclonal antibodies that reduce Pseudomonas aeruginosa burden in mice.
bioRxiv · Apr 8, 2024 · PreprintImmunology